Skip to main content
    N

    NRx Pharmaceuticals Inc (NRXPW)

    Official site

    BIOTECHNOLOGY

    $0.00
    -0.00 (-25.71%)

    Last updated: May 22, 2026 at 5:00 PM ET

    Earnings

    Upcoming Estimates

    Period ending Jun 30, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $1M
    Range$1M - $1M
    1 analysts
    Period ending Sep 30, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $1M
    Range$1M - $1M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Sep 26EST
    		-N/A---
    Jun 26EST
    		-N/A---
    Jun 21
    Reported Sep 30
    		$-0.40$0.00N/AMiss-14439.3%
    Mar 21
    Reported Jun 30
    		$-6.51$0.00N/AMiss-4280.9%
    Dec 20
    Reported Mar 31
    		$-2.26$0.00N/AMiss-
    Jun 20
    Reported Sep 30
    		$-0.15$0.00N/AMiss-
    Mar 20
    Reported Jun 30
    		$0.00$0.00N/ABeat-
    Dec 19
    Reported Mar 31
    		$-0.15$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.01
    SMA 20$0.01
    SMA 50$0.01
    SMA 200$0.06
    EMA 10$0.01
    EMA 20$0.01
    EMA 50$0.01
    EMA 200$0.05

    MACD

    Line: -0.00Signal: -0.00Hist: -0.00

    ADX

    ADX: 14.6+DI: 13.4-DI: 23.7

    Aroon & PSAR

    Aroon Up12.0
    Aroon Down100.0
    PSAR$0.01

    Bollinger Bands

    Upper Band$0.01
    Lower Band$0.00
    %B Position13905%(Upper)
    Band Width-0.00

    RSI (14-Day)

    Neutral
    37.6

    Momentum Oscillators

    Stoch %K8.5
    Stoch %D19.9
    Williams %R-99.1
    ROC (10d)-78.3%
    Momentum-0.01
    CCI (20d)-175.4
    MFI (14d)47.9

    Volatility Measures

    ATR (14d)$0.00(163.7%)
    StdDev (20d)0.00
    Hist Vol592.9%(High)

    Volume Flow

    VWAP$0.00
    OBV-1.3M
    AD Line-189.5K
    CMF (20d)0.014

    Volume Metrics

    Avg Vol (20d)53.7K
    Vol Ratio3.3x(High)
    VWMA (20d)$0.01

    Pivot Points

    R3$0.01
    R2$0.01
    R1$0.00
    Pivot Point$0.00
    S1$0.00
    S2$0.00
    S3$0.00

    Advanced Oscillators

    TSI-13.68
    Ultimate Osc49.5
    KST-233.13

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$1.07M$983,000$242,000$0$4,000$4,000$0$0$8,000$8,000$0$0
    Cost of Revenue$796,000$508,000$138,000N/A$2,000$1,000$2,000$1,000$1,000$1,000$2,000$1,000
    Gross Profit$272,000$475,000$104,000N/A$2,000$-1,000$-2,000$-1,000$-1,000$-1,000$-2,000$-1,000
    Operating Expenses$5.02M$5.07M$4.22M$3.73M$3.85M$3.63M$3.02M$7.05M$6.00M$4.41M$5.81M$7.94M
    R&D$1.31M$558,000$1.43M$987,000$804,000$1.04M$611,000$2.80M$1.75M$2.53M$3.31M$3.87M
    SG&A$3.81M$4.57M$2.81M$2.74M$2.94M$2.60M$2.41M$4.25M$4.25M$1.87M$2.49M$4.07M
    Operating Income$-4,748,000$-4,594,000$-4,118,000$-3,730,000$-3,847,000$-3,634,000$-3,022,000$-7,050,000$-5,998,000$-4,406,000$-5,808,000$-7,938,000
    Interest Income$5,000$4,000$2,000$2,000$4,000$4,000$6,000$7,000$27,000$74,000$119,000$145,000
    Interest Expense$233,000$671,000$0$0$0$0$0$849,000$230,000$80,000$40,000$0
    Income Before Tax$-1,430,000$360,000$-5,890,000$-17,581,000$-5,512,000$-9,078,000$-1,623,000$-7,897,000$-6,528,000$-4,332,000$-6,062,000$-8,717,000
    Income Tax Expense$0$0$0$0$0$0$0$0$-42,276$-1,394,000$40,000$-250,000
    Net Income$-1,430,000$360,000$-5,890,000$-17,581,000$-5,512,000$-9,078,000$-1,623,000$-7,897,000$-6,528,000$-4,332,000$-6,062,000$-8,717,000
    EBITDA$-4,583,000$-4,494,000$-4,077,000$-17,581,000$-5,512,000$-9,077,000$-1,621,000$-7,047,000$-6,297,000$-4,251,000$-6,020,000$-8,716,000
    EBIT$-4,748,000$-4,594,000$-4,118,000N/A$-9,078,000$-9,078,000$-1,623,000$-7,048,000$-6,298,000$-4,252,000$-6,022,000$-8,717,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NRXPW

    News

    No news available

    Company news will appear here when available

    NRXPW Competitors

    CompanyTicker
    China SXT Pharmaceuticals IncSXTC
    Biofrontera Inc. WarrantsBFRIW
    ProPhase Labs IncPRPH
    Celularity IncCELUW
    Scworx CorpWORX
    P3 Health Partners IncPIIIW
    Humacyte IncHUMAW
    NeuroSense Therapeutics Ltd. WarrantNRSNW

    Sector: Healthcare

    NRXPW Bull Case vs Bear Case

    Bear case

    • NRXPW beat EPS estimates in 16.7% of its last 6 reported quarters.

    NRXPW Earnings: Beat Rate and Next Report

    Beat rate
    1 of 6 quarters (16.7%)

    Frequently Asked Questions About NRXPW

    Does NRXPW pay dividends?

    NRx Pharmaceuticals Inc (NRXPW) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with N

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In